Doxazosin, Lisinopril, Omeprazole and Simvastatin price drop, UK
Main Category: Public HealthArticle Date: 02 Sep 2004 - 14:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
UK - The September Drug Tariff contains significant price reductions for Doxazosin, Lisinopril, Omeprazole and Simvastatin.
The reimbursement price of Drugs in Part 8, Category A of the Drug Tariff is based on a weighted average of the price of a product from two wholesalers (Unichem and AAH) and three generic manufacturers (APS, Alpharma and Ivax). The Department of Health have overriden the normal Drug Tariff rules and the lower reimbursement prices will apply to September 2004 prescriptions.
In early July, Lord Warner proposed to further reduce the reimbursement price for the '4 generics' from the 1st September 2004. The prices of these four medicines were first reduced on 1st December 2003 to address the significant differences between the reimbursement price and the price at which pharmacists were purchasing them from suppliers.
The PSNC, National Pharmacetical Association, Company Chemists Association and the Association of Independent Multiple Pharmacies submitted a joint response to the recent proposals. It is the belief of these organisations that removing money from reimbursement at this stage is wrong in principle.
The price changes can be found by clicking here and scrolling down a bit
Visit our public health section for the latest news on this subject.
MLA
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/12817.php>
APA
http://www.medicalnewstoday.com/releases/12817.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





